AstraZeneca to showcase transformative data across diverse pipeline at World Conference on Lung Cancer

AstraZeneca

Date 18 Jan 2021

AstraZeneca will present new data from across the innovative lung cancer portfolio at the IASLC 2020 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of Lung Cancer, 28 to 31 January 2021.

Eleven AstraZeneca medicines and potential new medicines from the pipeline feature in 39 abstracts showcasing the Company’s leadership across different types and stages of lung cancer, including eight oral presentations with two late breakers.

AstraZeneca to showcase transformative data across diverse pipeline at World Conference on Lung Cancer

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

Cambridge Science Centre Welcomes Brockton Everlast as New Executive Council Member New Three-Year Partnership to Develop Innovative Programme on the Built Environment

VeriPark Joins the Cambridge Science Park Community

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

You might also be interested in these articles

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

Cambridge Science Centre Welcomes Brockton Everlast as New Executive Council Member New Three-Year Partnership to Develop Innovative Programme on the Built Environment

VeriPark Joins the Cambridge Science Park Community

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs